Reporter Gene Assay for Monitoring BCL6 Reactivation

Catherine L Ingram1, Radosław P Nowak2, Thomas M Geiger3

  • 1Institute of Structural Biology, University of Bonn, Bonn, Germany.

Insights

Researchers developed a new assay to measure the activity of the BCL6 transcription factor using a small molecule activator. This method, utilizing luciferase reporter gene technology, offers a versatile platform for studying transcription factor drug targets.

Area of Science:

  • Molecular Biology
  • Drug Discovery
  • Epigenetics

Background:

  • Transcription factors are key regulators of gene expression and emerging drug targets.
  • Small molecule-induced proximity is a novel strategy to control transcription factor activity.
  • BCL6 is a significant transcription factor implicated in various cellular processes.

Purpose of the Study:

  • To develop and validate a transcriptional activity assay for the BCL6 transcription factor.
  • To demonstrate the utility of small molecule activators in modulating transcription factor function.
  • To establish a flexible assay adaptable for other transcription factors.

Main Methods:

  • Development of a luciferase reporter assay system in HEK293T cells.
  • Utilized transient transfection with BCL6-expressing and reporter plasmids.
  • Employed a specific BCL6 DNA-binding sequence to control luciferase expression.

Main Results:

  • Successfully established a functional assay to measure BCL6 transcriptional activity.
  • Demonstrated the ability of the small molecule activator TCIP1 to modulate BCL6 activity.
  • Validated the specificity of the assay for BCL6.

Conclusions:

  • The developed assay provides a robust method for studying BCL6 activity.
  • This platform enables the screening and characterization of small molecules targeting transcription factors.
  • The assay's adaptability facilitates research into diverse transcription factor drug targets.